Mrs Rachel Lee Bentley, MA | |
1300 N Miller Rd, Buckeye, AZ 85326-1000 | |
(623) 236-3685 | |
Not Available |
Full Name | Mrs Rachel Lee Bentley |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 1300 N Miller Rd, Buckeye, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861524498 | NPI | - | NPPES |
9888 | Other | CA | MEDI-CAL STAFF NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 50929 (California) | Secondary |
106H00000X | Marriage & Family Therapist | LMFT-15246 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Rachel Lee Bentley, MA Po Box 1118, Buckeye, AZ 85326-0083 Ph: (951) 704-8788 | Mrs Rachel Lee Bentley, MA 1300 N Miller Rd, Buckeye, AZ 85326-1000 Ph: (623) 236-3685 |
News Archive
Computed tomographic colonography (CTC), also known as virtual colonoscopy, remains effective in screening older patients for colorectal cancer (CRC), produces low referral for colonoscopy rates similar to other screening exams now covered by Medicare, and does not result in unreasonable levels of additional testing resulting from extracolonic findings, according to a study published in the February issue of Radiology.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that current and former users of marijuana are more likely to have prediabetes-the state of poor blood sugar control that can progress to type 2 diabetes-than never users of marijuana. However the researchers, led by Mike Bancks (University of Minnesota School of Public Health, Minneapolis, MN, USA) failed to establish a direct link between marijuana use and type 2 diabetes.
Entos Pharmaceuticals Inc. ("Entos" or the "Company"), a healthcare biotechnology company focused on the development of next-generation nucleic acid-based therapies using their Fusogenix drug delivery platform, today announced it has entered into a research, development and collaboration agreement ("Agreement") with a clinical stage biopharmaceutical company ("Partner") focused on the development of novel therapeutic compounds targeting autoimmune and inflammatory diseases.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has entered into a research and exclusive license agreement with Teva Pharmaceutical Industries Ltd. to develop and commercialize XMT-1107, a novel fumagillin analog, for the treatment of all indications, including cancer.
Using a wearable neuromuscular device can reduce the risk of ACL injury in female soccer athletes, according to new research presented today at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Colorado Springs, CO.
› Verified 5 days ago
Dr. Lavarez Dell Harris, ED.D, LMFT, CLC Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 26641 W Matthew Dr, Buckeye, AZ 85396 Phone: 949-275-4499 | |
Liana Lucille Hoover, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 20882 W Eastview Way, Buckeye, AZ 85396 Phone: 623-248-1704 |